Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
批准号:
10328140
负责人:
Daniel Kulp
金额:
$124.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-22 至 2025-08-31
关键词:
2019-nCoVAddressAdjuvantAntibodiesAntibody RepertoireAntibody ResponseAntigensAutomobile DrivingB-LymphocytesBindingBinding SitesCD8-Positive T-LymphocytesCOVID-19 therapeuticsCOVID-19 vaccinationCOVID-19 vaccineCoronavirusCoronavirus InfectionsCryoelectron MicroscopyDNADNA VaccinesDevelopmentDevicesDisease OutbreaksDoseElectroporationEpitopesEscape MutantFDA Emergency Use AuthorizationFrequenciesGenerationsGeneticGenetic RecombinationHumanImmune SeraImmune responseImmunityImmunizationImmunization ProgramsInvestigationLibrariesMiddle East Respiratory Syndrome CoronavirusModelingMolecularMutagenesisMutateMutationNucleic AcidsPhenotypePreclinical TestingPublishingRegimenResearch Project GrantsSARS coronavirusSARS-CoV-2 spike proteinSiteTechnologyTransgenic AnimalsVaccine Clinical TrialVaccinesVariantVirusWidespread Diseaseanimal databasebetacoronavirusclinical translationcombatcoronavirus receptorcoronavirus vaccinecross reactivitydesignexperimental studyhuman coronavirusimmunogenicityinterestlead candidatemutantnanoparticlenanoparticle deliverynanovaccineneutralizing antibodynovelnovel coronavirusnucleic acid deliverypandemic diseasepathogenic virusplasmid DNApre-clinicalprogramsreceptorreceptor bindingsynergismuniversal coronavirus vaccinevaccine candidatevaccine developmentvaccinology
中文摘要
项目摘要
我们泛冠状病毒提案的第一个项目名为“开发针对多种疾病的广泛纳米疫苗”。
冠状病毒受体结合位点。我们团队的专业知识将在结构引导的冠状病毒
纳米颗粒疫苗扩大CoV疫苗保护。该提案利用我们的新平台,
开发有效的、以RBS为焦点的纳米颗粒疫苗,以诱导跨CoV谱系的广泛保护,
逃逸突变和潜在的大流行性冠状病毒。项目的目标是:(1)创建一个
逃避冠状病毒免疫的突变体库(2)开发RBS聚焦的纳米颗粒疫苗,
使用核酸递送针对保守位点的广泛中和抗体和(3)开发疫苗方案
以在不同的CoV中诱导广泛的免疫和保护。
英文摘要
Project Summary
The first project of our pan-CoV proposal is titled ‘Development of broad nanovaccines targeting diverse
coronavirus receptor-binding sites’. Our team’s expertise will culminate in structurally guided coronavirus
nanoparticle vaccines to broaden CoV vaccine protection. This proposal utilizes our novel platform to
develop potent, RBS-focused nanoparticle vaccines to induce broad protection across CoV lineages,
escape mutations and potential pandemic CoVs that are of concern. The project aims are: (1) Create a
library of mutants that escape coronavirus immunity (2) Develop RBS-focused nanoparticle vaccines to induce
broadly neutralizing antibodies to conserved sites using nucleic acid delivery and (3) Develop vaccine regimens
to induce broad immunity and protection across diverse CoVs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice
-
批准号:10619836
-
项目类别:
-
资助金额:$84.31万
-
财政年份:2022
-
负责人:Daniel Kulp
-
依托单位:
Structural vaccinology guided development of a universal CoV vaccine utilizing nucleic acid delivered nanoparticles
-
批准号:10328138
-
项目类别:
-
资助金额:$262.68万
-
财政年份:2022
-
负责人:Daniel Kulp
-
依托单位:
Refinement of DNA-Launched NanoParticles decorated with Apex and CD4bs B cell lineage targeting Envs (DLNP-ACEs)
-
批准号:10589588
-
项目类别:
-
资助金额:$116.34万
-
财政年份:2022
-
负责人:Daniel Kulp
-
依托单位:
Development of Broad Coronavirus Immunity Targeting the Fusion Peptide
-
批准号:10424573
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2021
-
负责人:Daniel Kulp
-
依托单位:
Development of Broad Coronavirus Immunity Targeting the Fusion Peptide
-
批准号:10303447
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2021
-
负责人:Daniel Kulp
-
依托单位:
海外基金